CROs/Service Providers

Six pharmas employing Epic Sciences’ circulating tumor cell technology

Wednesday, August 15, 2012 10:38 AM

Epic Sciences, a privately held cancer diagnostics company of La Jolla, Calif., has established collaborations with six pharmaceutical partners employing Epic’s proprietary Circulating Tumor Cell (“CTC”) technology.

More... »


Quintiles acquires Expression Analysis to advance personalized medicine

Monday, August 13, 2012 12:02 PM

Quintiles, a fully integrated biopharmaceutical services company, has acquired Expression Analysis (EA), a Durham, N.C.-based provider of genomics testing and analysis to biopharma, academic, government and non-profit customers. Terms of the transaction were not disclosed.

More... »


Pluristem, Cato Research collaborate on intermittent claudication

Monday, August 13, 2012 11:32 AM

Pluristem Therapeutics, a developer of placenta-based cell therapies based in Israel, has selected Cato Research as its CRO for the German portion of the company's phase II trial in intermittent claudication (IC) under the auspices of the Paul-Ehrlich Institute (PEI).

More... »

CareSouth's expands in Florida, creates jobs in Georgia

Friday, August 10, 2012 12:50 PM

CareSouth Health System, a provider of non-acute care, has expanded its health care services throughout Florida with the purchase of key assets of Alliance Care, a provider of home health care, private duty and physician house call services.

More... »

Almac enhances service offering in refrigerated storage

Wednesday, August 8, 2012 11:38 AM

Almac, a global service provider based in Ireland, has further enhanced its service offering with the completed expansion of refrigerated (2-8°C) storage and newly developed refrigerated labelling facilities at its U.K. site. 

More... »

DKSH divests contract manufacturing plant OLIC to Fuji Pharma

Wednesday, August 8, 2012 10:47 AM

DKSH, a market expansion services provider with a focus on Asia, has agreed to divest OLIC, a contract manufacturing operation of pharmaceutical products in Thailand, to Fuji Pharma of Japan. The transaction is subject to customary closing conditions.

More... »

Icon to expand hospital-based presence in translational medicine

Wednesday, August 8, 2012 10:26 AM

Icon, a global provider of outsourced development services, has announced plans to further expand its U.K. hospital-based presence on the Manchester Royal Infirmary Campus.

More... »

Theorem and Gallus ink exclusive partnership

Wednesday, August 8, 2012 10:15 AM

Theorem Clinical Research, a global provider of comprehensive clinical research and development services, has entered an exclusive partnership with Gallus BioPharmaceuticals, a contract manufacturing company based in St. Louis, Mo., to help both companies accelerate their research, development and manufacturing of biopharmaceuticals.

More... »

Mission Search to provide commissioning services for Sensus Healthcare

Wednesday, August 8, 2012 10:01 AM

Mission Search, a Tampa, Fla.-based healthcare search and staffing organization, is has joined forces with Sensus Healthcare, a Boca Raton, Fla.-based company focused on skin cancers, to provide commissioning services to Sensus’ clientele.

More... »

German CRO Verum.de opens U.S. office

Wednesday, August 8, 2012 09:24 AM

Verum.de, a German-based CRO, has opened a new office in Carlsbad, Calif.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs